We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Diagnostics

Image: The new Guardant360 Liquid CDx assay measures a 100‑fold wider genomic footprint than the previously approved Guardant360 CDx (Photo courtesy of Guardant Health)

FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling

Guardant360 Liquid CDx is the largest FDA-approved liquid biopsy panel, assessing a 100-fold wider genomic footprint than the previous Guardant360 CDx. More...
21 May 2026
Image: The approach profiles bacteria in saliva and applies machine-learning algorithms to distinguish patients with ESCC from unaffected controls (image credit: Adobe Stock)

Microbial Saliva Test Could Help Triage Esophageal Cancer Risk

An AI approach using saliva microbiome profiles flags esophageal squamous cell carcinoma, outperforming clinical variables. More...
21 May 2026
Image: The original Yourgene DPYD test has been enhanced to detect 19 variants, including 14 recommended by updated guidelines and five additional variants for broader global coverage (photo courtesy of Yourgene Health)

Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing

A new DPYD genotyping test broadens coverage to 19 variants, delivering same-day results to guide safer chemotherapy dosing. More...
20 May 2026
Image: The integrated multi-omics approach may help identify bladder cancer patients likely to respond to BCG and those needing alternative or intensified treatment (image credit: iStock)

Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cancer

An AI-enabled multi-omics model stratifies high-risk bladder tumors and predicts recurrence and BCG response to guide care. More...
20 May 2026
Image: A novel computational tool can accurately identify RFC1 genetic changes linked to certain forms of peripheral neuropathy (photo courtesy of Adobe Stock)

New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy

An AI approach to genome analysis identifies hard-to-detect genetic expansions, improving diagnosis of unexplained neuropathy. More...
20 May 2026
Image: Researchers identified eight new DNA pattern signatures that could help refine diagnostics and guide targeted therapy in breast cancer (image credit: 123RF)

Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

Researchers identify eight breast cancer copy-number signatures to improve detection and guide terapy selection. More...
19 May 2026
Image: TrueMRD uses a whole-genome, tumor-informed approach that analyzes patient-specific tumor variants across the entire genome in every sample tested (photo courtesy of Veracyte)

Whole-Genome MRD Test Detects Early Recurrence in Muscle-Invasive Bladder Cancer

A new whole-genome MRD test gains Medicare coverage to detect post-treatment MIBC recurrence months earlier than imaging. More...
19 May 2026
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Hematology Consumables
Bioblood Devices


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.